DUBLIN, Ireland & ANAHEIM, Calif.--(BUSINESS WIRE)--Mallinckrodt plc (NYSE: MNK), and Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Mallinckrodt’s proposed acquisition of Questcor, was terminated by the United States Federal Trade Commission on May 9, 2014.
Help employers find you! Check out all the jobs and post your resume.
